Acerus Pharmaceuticals Corporation is a specialized drug company dedicated to the creation, production, promotion, and distribution of pharmaceutical products tailored for men's and women's health. Its current product lineup includes Natesto, a nasal gel designed for testosterone replacement therapy in adult males diagnosed with hypogonadism. Another key offering is Noctiva, a vasopressin analog indicated for the treatment of nocturia (frequent nighttime urination) caused by nocturnal polyuria in adults who awaken at least two times per night to void.